# A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors

Source: https://nuclide.cc/trials/nct07691775/  
Nuclide record `nct07691775` (Trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of F18 FBPA Injection in advanced solid tumours, run by Heron Neutron Medical Corp., now recruiting.

## Summary

A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors is a phase 1/2 interventional study registered as NCT07691775 by Heron Neutron Medical Corp., with 30 participants planned, started 2026-05-20 and due to reach its primary completion in 2026-12. Interventions recorded: F18 FBPA Injection.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07691775
- Phase: 1/2
- Setting: A Study to Evaluate the Safety and Diagnostic Performance of F18 FBPA PET/CT Imaging in Solid Tumors
- Sponsor: Heron Neutron Medical Corp.
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT07691775: https://clinicaltrials.gov/study/NCT07691775

## Connected records

- isotopes: [Fluorine-18](https://nuclide.cc/isotopes/f-18/)
- technologies: [PET (positron emission tomography)](https://nuclide.cc/technologies/pet/), [PET/CT](https://nuclide.cc/technologies/pet-ct/)

---
JSON: https://nuclide.cc/api/v1/entities/nct07691775.json